Abithas, Inc. is a medical device enterprise with the InspirEaseHFA solution to the problem of inhaler misuse, affecting over 55 million U.S. asthma and COPD sufferers. Up to 90% of asthma and COPD inhaler users may fail to obtain the intended benefits from their medications due to inhaler misuse. The InspirEaseHFA solves the problem of inhaler misuse, reducing healthcare disparity and billions in costs attributed to inhaler misuse.